Blue Horseshoe Stocks: PZRX Review & More

PhaseRx, Inc. PZRX

It seems like most of the big runners we’ve caught up with in recent weeks have been pharma plays of one type or another, and that trend continued yesterday. PZRX was the standout performer from our premarket watchlist, trading in a rather impressive range throughout essentially the entire session.

The stock saw an early low of .82, and surged continuously up to a high of  1.55 roughly an hour before the close. It worked out to an intraday swing of 89% and came on fantastic liquidity, with more than 43X the monthly average volume flowing through the PZRX.

The stock closed with strength in the high 1.20′s and is inching back into the 1.30′s in the premarket. The move was catalyzed by the company’s 2nd drug development candidate, PRX-ASL, for the treatment of ASLD, a rare liver disorder, has received orphan drug status by the FDA. (>>View PR)

.We’ll continue to track its activity and look for higher lows and higher highs as we head into week’s end.


Iconic Brands, Inc. ICNB

We tagged ICNB as a bottom-watch play early in the week, and have begun to see the rebound that we were looking for.

We subsequently observed a low of .0058, and yesterday with the stock reaching .008, it marked an intraweek swing of 38% Once again, we’ll be looking for the establishment of higher highs and higher lows in forthcoming sessions.



SeaDrill Ltd. SDRL

Speaking of excellent bottom calls, we’ve had an even better one in SDRL. We highlighted this one in our report last Wednesday, after which time we observed the stock at a low of .22. Yesterday it attained a .62 high, representing an upswing of 182% over the span of just a few sessions. Once more, we’ll be looking out for a more sustained recovery


Anadarko Petroleum Corp. APC

We want to put a few sets of options contracts from the APC chain on watch today after noticing the annoucement of a massive share buyback program by the company to the tune of $2.5B, effectively reducing the number of outstanding shares by 10%

The stock has tested an area of recent resistance as a result in premarket trading. We’re going to radar the APC 09/29 $47-48.50 Calls, and watch them into next week.


Extended Watchlist:
VEON, BCRX, ITUS, EGO, ESNC, ABUS, BSTI

Blue Horseshoe Stocks: CAPR Recap & More

Capricor Therapeutics, Inc. CAPR

We included CAPR in yesterday’s premarket watchlist after noticing some abnormal volume and price action in the stock during the previous session. Prior to that it had been trading sideways for more than a month.

It turns out our alert came just in the nick of time, because yesterday CAPR exploded for its largest single-session spike in years. The stock opened at 1.50 and managed to run as high as 2.65, filling a good portion of the large gap on its chart, left in May. It came out to an intraday push of 77% which came on monstrous volume of just under 80 times the monthly average.


SPDR S&P500 ETF (SPY)

We discussed tracking the SPY Weekly $249.50 & $250 Calls as conditions appeared favorable to another bullish day for the market in general. The fund made a pretty solid move during the session, and that produced some decent opportunities in our designated contracts.

The $249.50′s traded from .55 to a high of .83 (+51%), while the $250′s did slightly better with a run from .29 to .49 (+69%) just before lunch hour.


Helios and Matheson Analytics, Inc. HMNY

We last tagged HMNY on August 15th, and after a solid run, the stock went under consolidation for a few weeks. However, the downturn ended at the end of last week and the move it’s made since has been pretty impressive.

HMNY saw a low of 2.42 on Thursday, and yesterday the stock achieved a new high of 6.40. That represents a four -session upswing of 164% while volume over the same period has been significantly increased.


HTG Molecular Diagnostics, Inc. HTGM

We’re interested to track HTGM today after the company announced the issuance of two method patents on its technology. We’re seeing a moderate gap-up in the premarket, but there still appears to be the good chance for a solid upside here. The stock does have a recent history containing a huge spike to more than $12.

We’ll place it on watch, and look for it to establish a string of sessions recording higher highs and higher lows moving forward.


Extended Watchlist:
WAC, DMPI, KPTI, SPI, ARWR, ALRT, PZRX, CEI

Blue Horseshoe Stocks: DMTX Review, Options & More

Dimension Therapeutics, Inc. DMTX

We alerted on DMTX after a sizable gap-up few weeks back on the morning of August 25th. That day we would observe a low of 2.90 in the stock, and it never looked back.

Throughout the month of September the stock has mostly been stair-stepping its way up in steady fashion, but news of an unsolicited buyout offer (@5.50/share) kicked this play into a much higher gear to start things off this week, and yesterday DMTX attained a high of 5.90.

That works out to a three-week double-bag swing of 103% We wouldn’t expect to see the stock travel much higher, certainly not without confirmation or further details on a proposal, but will still keep our eyes open for further activity after a very strong session yesterday.


Fresh Options Ideas

We’ve got a pair of options possibilities  to present this morning. Yesterday’s market sentiment was exceedingly bullish, with more than 65% of NASDAQ quoted stocks trading at or above their 50-day moving averages.

Today, better than expected numbers on Housing Starts and Building Permits were reported, which could assist in keeping the momentum moving.

SPDR S&P500 ETF (SPY) – For a direct market analog, we generally turn to the SPY, having had immense success with it on several separate occasions in the past. We’re going to signal the SPY Weekly $249.50 & $250 Calls for observation as we approach midweek.
_____

The Kroger Co. KR – We’re also noticing a heck of a bottom setup on KR. A strong multiple bottom signal showing the stock at a solid support level, and a couple of gaps to the upside on the chart leaves us looking at a pair of longer-term contracts. We’re going to place the KR 11/17 $23 & $24 Calls on watch in the event of a recovery for Kroger.


Extended Watchlist:
STAF, CAPR, MRTX, NTEC, NBRV, RNVA, AGTC

Blue Horseshoe Stocks: MRTX Recap & More

 Mirati Therapeutics, Inc. MRTX

After reporting positive cancer trial results on Friday, we talked about MRTX being poised for a big move and we weren’t incorrect.

The stock exploded out of the gate right from the outset, and traded in an impressive range from 9.15 to 12.40 early on in the day. That was good for a 35% intraday run- excellent for a $9+ stock. This is the third time in as many weeks we’ve called a stock that was approaching the ten dollar range and saw it gain more than a third in value in a single session.

Not only did MRTX trade up big on many times more thanits average volume, but it managed to maintain well over half of its daily advance, so we’ll be interested to continue monitoring its activity as we kick off a fresh trading week.


Iconic Brands, Inc. ICNB

We want to place ICNB on bottom-watch after taking a look at the recent history of the chart. This stock exhibits some really nice volatility and is coming down off of a significant spike.

When it finds support and rebounds, we could see a notable swing trade opportunity. The last such swing took the stock from the .003 range to .014.

The company recently announced its brand of Prosecco endorsed by former supermodel Christie Brinkley would be carried by Publix stores, so we’ll also be looking for further updates on that part of the story as well.


Pluristem Therapeutics, Inc. PSTI

We tagged PSTI for observation roughly a month ago, and have since seen a moderate move up on the chart, and will want to continue monitoring the situation.

The run the stock has made thus far is a marginal 27%, but things this morning have taken an interesting turn as the company announced the FDA granted fast track status to one of its treatments.


Extended Watchlist:
RAD, ADYN, NBRV, ARWR, PTIE, BIOA, MBOT, TRXC, COGT

Blue Horseshoe Stocks: ALDX Review & More

Aldeyra Therapeutics, Inc. ALDX

The big standout from yesterday morning’s premarket report turned out to be ALDX, which initially drew our attention with an abnormal volume signal, and the release of positive Phase 2a study data for a Dry Eye Disease treatment.

The stock recorded a continuously bullish pattern throughout the day, trading in an impressive range. From it’s early morning low of 6.60, the stock reached a high of 11.05 just prior to the closing bell. That’s an increase 67% on the day, on more than twenty times the monthly average volume. It also easily took the top gainer spot on the NASDAQ board for the session.

ALDX increasing in value by two-thirds in a single session worked well for us yesterday, but such moves also rare and often unsustainable events. It’s difficult to imagine a scenario where the stock doesn’t undergo a consolidation in the session or sessions to come.


Macy’s, Inc. M – Options Review

We want to swing back around for a recap of the performance in a set of Macy’s calls we made a few weeks ago as a longer-term options idea. Typically, when a stock seems set for an extended rebound, we’ll signal contracts whose expiration doesn’t occur for a longer period of time. In this case we highlighted the

It worked out nicely, with M stock making a steady increase over these last few weeks that facilitated a move in those calls from .60-1.37, which comes out to a respectable gain of 128%

______

Fresh Idea:

We also look for quick strike chances as well, and may have one with Mirati Therapeutics, Inc. MRTX today after the stock soared following the presentation of positive cancer trial data at a conference in Chicago.

We’ll be looking for a dip-and-rip pattern off of this morning’s significant premarket gap-up, and will be tracking the MRTX Weekly $7.50 Calls* and possibly even the $10′s if it appears as if MRTX wants to break that ten dollar barrier.

*Never attempt to trade weekly options on a Friday unless you are A.) An expert trader and B.) Have money you can afford to lose. It’s an extremely risky proposition.


Extended Watchlist:
LPTH, ARRY, MBOT, ATOS, RXII